Found 66 All Conditions trials

Below is a list of actively recruiting clinical trials based on your search for "All Conditions"

18 years or above
All genders
Phase 3
Interventional
This study investigates chronic lung allograft dysfunction. It focuses on evaluating the effectiveness and safety of an investigational medication.The study evaluates how the investigational medication works compared to a placebo. It looks at safety and effectiveness when used with standard treatments.Who can participate: Adults aged 18 and older who are …
18 years - 75 years
All genders
Phase 2
Interventional
This study evaluates the effectiveness and safety of an investigational medication for adults with ulcerative colitis.The study investigates the safety and effectiveness of different doses of the investigational medication. It focuses on understanding how well the medication works and how safe it is for participants.Who can participate: Adults aged 18 …
16 years - 80 years
All genders
Phase 3
Interventional
This study investigates how an investigational medication might work for people with ulcerative colitis.The purpose of this study is to evaluate the efficacy and safety of the investigational medication. It focuses on how well the medication works and how safe it is for participants.Who can participate: Participants aged 16 to …
16 years - 80 years
All genders
Phase 3
Interventional
This study is focused on participants with moderately to severely active ulcerative colitis.The study evaluates the safety and effectiveness of an investigational medication over a long-term period. The purpose of this study is to gather data on how well participants tolerate the treatment.Who can participate: Participants aged 16 to 80 …
60 years or above
Accepts healthy volunteer
All genders
Phase 1/2
The purpose of this study is to investigate a vaccine candidate for respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) in adults aged 60 and older. The study focuses on these conditions to gather data for further clinical development.This study evaluates the safety and immune response to the investigational vaccine. …
6 months - 17 years
All genders
Phase 3
Interventional
This study investigates prurigo nodularis in children and teens. The purpose of this study is to understand how the investigational medication is processed in the body and to evaluate its safety in participants with prurigo nodularis.The study evaluates the safety and how the body absorbs, distributes, and gets rid of …
6 months - 6 years
All genders
Phase 3
Interventional
This study investigates eosinophilic esophagitis. The purpose of this study is to evaluate an investigational medication in small children with this condition.The study evaluates the safety, tolerability, and effectiveness of the investigational medication over a 24-week period. It also looks at potential side effects, how the medication is processed in …
18 years or above
All genders
Phase 1/2
Interventional
This study investigates rheumatoid arthritis. It evaluates the investigational medication administered intravenously to understand its pharmacokinetic (PK) parameters and safety in adults with this condition.The focus is on assessing the safety and PK parameters of the investigational medication, both with and without additional conventional treatments for rheumatoid arthritis.Who can participate: …
Accepts healthy volunteer
All genders
Observational
This study investigates the effects of an investigational vaccine on pregnancy outcomes. The study focuses on exposure to the vaccine during pregnancy.The study evaluates various outcomes related to maternal health, obstetrical events, and infant development. It focuses on understanding the effects of the investigational vaccine on both mothers and their …
18 years or above
All genders
Observational
This study investigates chronic inflammatory demyelinating polyneuropathy (CIDP).The study evaluates treatment outcomes for people with CIDP who have received standard of care therapy for at least three months.Who can participate: Adults aged 18 and older with a neurologist-confirmed diagnosis of CIDP and ongoing treatment for at least three months, who …